A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSt. Mary's University, Twickenham
About this trial
A small-scale test of the intervention, trial design and methods to explore the cumulative effectiveness of two commonly used prescribing strategies for patients with long COVID: Treatment A - prescribing a specific homeopathic remedy for long COVID, plus or minus Treatment B - a course of individually tailored treatment by a homeopath. Both interventions compared to usual care
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults who experienced acute COVID-19 at least 12 weeks ago
A medical diagnosis of long COVID (diagnosis by a healthcare professional, documentation from an NHS long COVID clinic, or equivalent formal medical verification)
At least one recognized long COVID symptom according to NHS criteria
Agreement to be contacted again and interest in participating in research.
Disqualifiers
Those who have not had acute COVID-19
Those who have not received a medical diagnosis of long COVID
Those not currently experiencing symptoms (MYMOP average score 1 or less)
Inability to give informed consent
Trial design
Design model
Sequential
Treatments tested in this trial
Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID
Other interventionprescription of a specific homeopathic remedy for long COVID
a course of individually tailored treatment by a homeopath
Other interventionA series of up to four consultations with a homeopath, one month apart, and at the end of each consultation the homeopath prescribes an individually tailored homeopathic remedy
Treatment groups
120 Participants
are divided into 3 treatment groupsGroup A: Treatment AActive comparator 1 intervention
Group B: Treatment BActive comparator 1 intervention
Group C: Usual care cohortNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Measure Your Own Medical Outcome Profile (MYMOP)
The participant chooses two symptoms that bother them the most. They also choose an activity of daily living that is limited or prevented by their problem. These choices are written down in the patient's own words and the patient scores them for severity over the past week on a seven-point scale.
Time frame
monthly for 6 monthsSecondary outcomes
1
Wellbeing Health Survey Questionnaire (SF-36)
SF-36 consists of 36 items across eight health domains: physical functioning, role limitations due to physical and emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health. Each item employs various response formats such as Likert scales, yes/no answers, and frequency ratings to capture the respondent's health status over the past four weeks. After completion, scores for each domain are calculated by summing item responses and transforming them on a 0-100 scale, where higher scores indicate better health.
Time frame
monthly for 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
St. Mary's University, Twickenham
Lead sponsor
Institute for Ethical Research Governance
Collaborator
Homeopathy International
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: